{"status":"OK","copyright":"Copyright (c) 2020 Pro Publica Inc. All Rights Reserved.","results":{"votes":{"vote":{"congress":116,"session":1,"chamber":"Senate","roll_call":389,"source":"https://www.senate.gov/legislative/LIS/roll_call_votes/vote1161/vote_116_1_00389.xml","url":"https://www.senate.gov/legislative/LIS/roll_call_lists/roll_call_vote_cfm.cfm?congress=116&session=1&vote=00389","bill":{"bill_id":"s2740-116","number":"S.2740","api_uri":"https://api.propublica.org/congress/v1/116/bills/s2740.json","title":"A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.","short_title":"Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019","latest_action":"Referred to the House Committee on Energy and Commerce."},"amendment":{},"question":"On Passage of the Bill","question_text":"On Passage of the Bill S. 2740","description":"A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.","vote_type":"1/2","date":"2019-12-10","time":"15:15:00","result":"Bill Passed","tie_breaker":"","tie_breaker_vote":"","document_number":"2740","document_title":"A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.","democratic":{"yes":39,"no":0,"present":0,"not_voting":6,"majority_position":"Yes"},"republican":{"yes":51,"no":2,"present":0,"not_voting":0,"majority_position":"Yes"},"independent":{"yes":1,"no":0,"present":0,"not_voting":1},"total":{"yes":91,"no":2,"present":0,"not_voting":7},"positions":[]},"vacant_seats":[]}}}